Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lluís Cirera
Pharmacogenetic Clinical Randomised Phase II Trial to Evaluate the Efficacy and Safety of FOLFIRI With High-Dose Irinotecan (HD-FOLFIRI) in Metastatic Colorectal Cancer Patients According to Their UGT1A 1 Genotype
British Journal of Cancer
Cancer Research
Oncology
A Combined Analysis of the Short-Term Effects of Photochemical Air Pollutants on Mortality Within the EMECAM Project
Environmental Health Perspectives
Mutagenesis
Public Health
Environmental
Health
Toxicology
Occupational Health
Related publications
A Phase 2 Randomised Study of Veliparib Plus FOLFIRI±bevacizumab Versus Placebo Plus FOLFIRI±bevacizumab in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
A Randomised, Double-Blind, Placebo-Controlled Multi-Centre Phase III Trial of XELIRI/FOLFIRI Plus Simvastatin for Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
A Phase I Study of Intravenous Aflibercept With FOLFIRI in Japanese Patients With Previously Treated Metastatic Colorectal Cancer
Investigational New Drugs
Oncology
Pharmacology
FOLFIRI® and Bevacizumab in First-Line Treatment for Colorectal Cancer Patients: Safety, Efficacy and Genetic Polymorphisms
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
An Open, Multi-Centre, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Paclitaxel, UFT, and Leucovorin in Patients With Advanced Gastric Cancer
British Journal of Cancer
Cancer Research
Oncology
P16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients With Metastatic Colorectal Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Erratum To: UDP-glucuronosyltransferase 1A1*6 and *28 Polymorphisms as Indicators of Initial Dose Level of Irinotecan to Reduce Risk of Neutropenia in Patients Receiving FOLFIRI for Colorectal Cancer
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Phase I Trial of Irinotecan, Infusional 5-Fluorouracil, and Leucovorin (FOLFIRI) With Erlotinib (OSI-774): Early Termination Due to Increased Toxicities
Clinical Cancer Research
Cancer Research
Oncology
Bifractionated CPT-11 With LV5FU2 Infusion (FOLFIRI-3) in Combination With Bevacizumab: Clinical Outcomes in First-Line Metastatic Colorectal Cancers According to Plasma Angiopoietin-2 Levels
BMC Cancer
Cancer Research
Oncology
Genetics
